Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an e... Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage. Mehr anzeigen
Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock PR Newswire WALTHAM, Mass., Nov. 18, 2024 WALTHAM, Mass., Nov. 18, 2024 /PRNewswire/ -- Spyre Therapeutics...
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock and Pre-Funded Warrants PR Newswire WALTHAM, Mass., Nov. 18, 2024 WALTHAM, Mass., Nov. 18, 2024 /PRNewswire/ -- Spyre...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -5.95 | -18.0139267333 | 33.03 | 33.47 | 25.74 | 1094318 | 27.60225102 | CS |
| 4 | -6.78 | -20.0236266982 | 33.86 | 40.26 | 25.74 | 632747 | 32.16743473 | CS |
| 12 | -1.32 | -4.64788732394 | 28.4 | 40.26 | 25.74 | 560319 | 30.52739182 | CS |
| 26 | -9.22 | -25.3994490358 | 36.3 | 40.26 | 22.19 | 553607 | 29.16961351 | CS |
| 52 | 16.27 | 150.508788159 | 10.81 | 47.97 | 10.42 | 466993 | 30.02284825 | CS |
| 156 | 16.27 | 150.508788159 | 10.81 | 47.97 | 10.42 | 466993 | 30.02284825 | CS |
| 260 | 16.27 | 150.508788159 | 10.81 | 47.97 | 10.42 | 466993 | 30.02284825 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
